Non-Interventional Weight Changes Are Associated with Alterations in Lipid Profiles and in the Triglyceride-to-HDL Cholesterol Ratio.

Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6643 (Electronic) Linking ISSN: 20726643 NLM ISO Abbreviation: Nutrients Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI Publishing

Obesity*; Humans ; Triglycerides ; Cholesterol, HDL ; Cholesterol, LDL ; Retrospective Studies

Background: Obesity is associated with dyslipidemia, and weight loss can improve obese patients' lipid profile. Here, we assessed whether non-interventional weight changes are associated with alterations in lipid profile, particularly the triglyceride (TG)-to-high-density lipoprotein cholesterol (HDL-C) ratio (TG/HDL-C).
Methods: In this retrospective analysis of subjects referred to medical screening, body mass index (BMI), low-density lipoprotein cholesterol (LDL-C), TG, and HDL-C levels were measured annually. Patients were divided according to BMI changes between visits. The primary outcomes were the changes in LDL-C, TG, HDL-C, and the TG/HDL-C ratio between visits.
Results: The final analysis included 18,828 subjects. During the year of follow-up, 9.3% of the study population lost more than 5% of their weight and 9.2% gained more than 5% of their weight. The effect of weight changes on TG and on the TG/HDL-C ratio was remarkable. Patients with greater BMI increases showed greater increases in their TG/HDL-C ratio, and conversely, a decreased BMI level had lower TG/HDL-C ratios. This is true even for moderate changes of more than 2.5% in BMI.
Conclusions: Non-interventional weight changes, even modest ones, are associated with significant alterations in the lipid profile. Understanding that modest, non-interventional weight changes are associated with alterations in the TG/HDL-C ratio may aid in better risk stratification and primary prevention of CV morbidity and mortality.

Nutr Metab Cardiovasc Dis. 2022 May;32(5):1165-1174. (PMID: 35260316)
Diabetes Res Clin Pract. 2016 Oct;120:156-61. (PMID: 27565692)
Ann Intern Med. 2023 Jan;176(1):10-21. (PMID: 36508737)
Trends Cardiovasc Med. 2016 May;26(4):364-73. (PMID: 26654259)
Scand J Surg. 2014 Mar;103(1):21-5. (PMID: 24177986)
Front Cardiovasc Med. 2020 May 13;7:88. (PMID: 32478100)
N Engl J Med. 2009 Feb 26;360(9):859-73. (PMID: 19246357)
Curr Opin Lipidol. 2000 Feb;11(1):65-70. (PMID: 10750696)
Stroke. 2019 Dec;50(12):3376-3384. (PMID: 31658904)
Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1872-1879. (PMID: 35753859)
J Int Med Res. 2023 Mar;51(3):3000605231164548. (PMID: 36994866)
J Cardiovasc Dev Dis. 2023 Mar 16;10(3):. (PMID: 36975891)
Atherosclerosis. 2015 Apr;239(2):629-33. (PMID: 25683387)
Nutrients. 2020 Apr 02;12(4):. (PMID: 32252374)
Vascular. 2020 Oct;28(5):513-519. (PMID: 32390562)
J Geriatr Cardiol. 2022 Jun 28;19(6):456-468. (PMID: 35845160)
Clinics (Sao Paulo). 2008 Aug;63(4):427-32. (PMID: 18719750)
Cardiovasc Diabetol. 2008 Feb 28;7:4. (PMID: 18307789)
Ann Intern Med. 2006 Jan 3;144(1):21-8. (PMID: 16389251)
Curr Cardiol Rep. 2013 Sep;15(9):400. (PMID: 23881582)
Eur Heart J Qual Care Clin Outcomes. 2021 Jan 25;7(1):109-110. (PMID: 32129832)
Nutrients. 2018 Dec 20;11(1):. (PMID: 30577478)
J Clin Med. 2023 Sep 16;12(18):. (PMID: 37762944)
Am J Cardiol. 2021 Mar 1;142:59-65. (PMID: 33301771)
Am J Cardiol. 1999 May 13;83(9B):25F-29F. (PMID: 10357572)
Mayo Clin Proc. 2017 Apr;92(4):680-681. (PMID: 28385200)
J Nutr Metab. 2019 Apr 01;2019:4729040. (PMID: 31061735)
Nat Rev Cardiol. 2023 Oct;20(10):685-695. (PMID: 37193856)
Nutrition. 2019 Jan;57:290-299. (PMID: 30219686)
Circ Res. 2020 May 22;126(11):1477-1500. (PMID: 32437302)
Nutrients. 2023 Mar 09;15(6):. (PMID: 36986072)
Front Cardiovasc Med. 2021 Aug 17;8:716698. (PMID: 34490378)
Circ Res. 2021 Apr 2;128(7):951-968. (PMID: 33793327)
J Investig Med. 2014 Feb;62(2):345-9. (PMID: 24402298)
Neurol Sci. 2023 Mar;44(3):835-843. (PMID: 36301362)
Nutr Diabetes. 2017 Dec 19;7(12):1. (PMID: 29259181)
J Clin Endocrinol Metab. 2020 Dec 1;105(12):. (PMID: 32954416)
Int J Environ Res Public Health. 2020 Aug 13;17(16):. (PMID: 32823485)
Am J Cardiol. 2005 Aug 1;96(3):399-404. (PMID: 16054467)
Heart Lung Circ. 2020 Mar;29(3):414-421. (PMID: 31014557)
Am J Cardiol. 2012 Jun 15;109(12):1749-53. (PMID: 22449634)
Hypertens Res. 2017 Dec;40(12):947-963. (PMID: 28978986)
Exp Clin Endocrinol Diabetes. 2001;109(4):S516-26. (PMID: 11453039)
Cardiovasc Diabetol. 2018 Aug 31;17(1):122. (PMID: 30170598)
Pathophysiology. 2022 Jul 17;29(3):374-382. (PMID: 35893599)
Ann Intern Med. 2003 Nov 18;139(10):802-9. (PMID: 14623617)
Diabetes Care. 2011 Oct;34(10):2152-7. (PMID: 21836103)
Diagnostics (Basel). 2023 Mar 01;13(5):. (PMID: 36900073)
Acta Endocrinol (Buchar). 2018 Apr-Jun;14(2):261-267. (PMID: 31149268)
Circulation. 2015 Feb 3;131(5):451-8. (PMID: 25623155)
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S15-S19. (PMID: 27575046)
Lancet. 2011 Mar 26;377(9771):1085-95. (PMID: 21397319)
BMJ. 2017 Nov 14;359:j4849. (PMID: 29138133)
Pak J Med Sci. 2022 Mar-Apr;38(3Part-I):624-631. (PMID: 35480530)

Keywords: BMI change; lipids; triglyceride-to-HDL ratio; weight change

0 (Triglycerides)
0 (Cholesterol, HDL)
0 (Cholesterol, LDL)

Date Created: 20240224 Date Completed: 20240226 Latest Revision: 20240227

20240227

PMC10892159

10.3390/nu16040486

38398811